Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials.

JNCI cancer spectrum(2023)

引用 2|浏览13
暂无评分
摘要
This study adds to the growing evidence demonstrating that concerns regarding open-label bias should not prohibit the interpretation of large and meaningful treatment effects on PROs.
更多
查看译文
关键词
melanoma,non-small cell lung cancer,open-label bias,patient-reported outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要